Medical Inflation Accelerates Health Insurance Costs: The Impact of Other Associated Risks

Dr. Abhijit K. Chattoraj

A question was raised in the Lok Sabha by an Hon’ble member of Parliament to the Ministry of Finance seeking clarification on the points stated below: 

a) Medical inflation rate for the financial years 2022-23, 2023-24, 2024-25 and 2025-26 till date ; 

(b) the correlation between the medical inflation rate and health insurance premium;

(c) the details of the rise in premium on health insurance on account of medical Inflation in FY 2022-23, 2023-24, 2024-25 and 2025-26 till date; and

(d) the details of the steps taken by the Insurance Regulatory and Development Authority of India (IRDAI) to ensure transparency in premium fixation?

In response to the above questions, the Hon’ble Minister of State in the Ministry of Finance on 16th March,2026 stated that, as for (a) to (c), the Insurance Regulatory and Development Authority of India (IRDAI) has informed that no specific study has been conducted by it on the rate of medical Inflation and its correlation with health insurance premium. Further, besides medical Inflation, several other factors may cause health insurance premiums to increase from year to year.

Some of the reasons are as follows:

i. Increase in average age of policyholders – As the insured population ages, health risks generally increase, leading to higher claims and, consequently, higher premiums for older ages.

ii. Increase in coverage or sum insured – If policyholders opt for higher coverage limits or additional benefits (e.g., OPD cover, maternity benefits, critical illness riders), the premium will rise.

iii. Change in policy features – Addition of new features and benefits such as enhanced sum insured limits, inclusion of top-up/super-top up coverage features, modern treatments coverage, pre-existing disease coverage (PED), removal of capping such as room rent capping, waiting periods, etc., can result in payment of a higher premium by policyholders.

As for question (d) , the following response : 

  • Periodic Product Review by Appointed Actuary: Under Regulation 6(3)(c) of IRDAI (Insurance Products) Regulations, 2024, the Appointed Actuary must periodically review products and ensure that premium or benefit revisions are based on credible risk experience, policyholder grievances and market feedback.
  • 2. Stringent Premium Regulation for Senior Citizens: As per the IRDAI Circular dated 30.01.2025, insurers cannot increase senior citizens’ health insurance premiums by more than 10% annually without prior consultation with IRDAI. Prior consultation is also required before withdrawing individual health insurance products for senior citizens.

These were pertinent questions put before the ministry as, year after year, premiums rise on the plea of medical Inflation. Let us try to understand the central concept and other related concepts.

Medical Inflation – Like the annual inflation rate, medical Inflation is the year-on-year change in the cost of providing the same set of healthcare services, in terms of both quality and quantity. Thus, it doesn’t consider changes in utilisation levels in terms of quality and quantity. 

  • India’s annual inflation rate was 4.2% in 2025, compared with 4.4% in 2024. This means the overall prices of goods and services in India increased by approximately 4.2% over one year. This indicates the year-on-year inflation rate from 2023 to 2024 and from 2024 to 2025. The above measurement differs from the CPI base year of 2012 = 100.

Suppose the average cost of monthly household goods and services was ₹10,000 in 2024 – the price of the same quality and quantity is  ₹10,420 in 2025. Thus, the increase is (10,420 – 10,000)/100, or 4.2%. The key comparison point here is that the quantity and quality are more or less similar.

Annual Medical Trend Rate –

Like medical Inflation, it measures the increase in healthcare costs over time and reflects rising costs of medical treatment and healthcare services. Both measures consider increases in hospital charges, doctors’ fees, medicines, diagnostics, and surgical procedures. Both help explain and project future healthcare spending and can impact health insurance premiums and employee medical benefit costs. However, medical Inflation measures increases in the prices of medical goods and services (medical prices) and, in turn, increases in total medical costs.

The Annual Medical Trend Rate measures the overall expected increase in medical claims or healthcare expenditure, reflecting price increases or decreases resulting from changes in utilisation patterns and treatment mix through innovation or better choices. In reality. It captures changes in the medical cost/claims experience.

It may noted here that India’s Annual General inflation rate in 2025 is 4.2 % ; the annual gross medical trend rate is 13%, and the annual net medical trend rate is 8.8% (Source: 2025 Global Medical Trend Rates Report) 

The annual (gross) medical trend rate reflects the annual increase in the cost of medical services and healthcare before accounting for general Inflation. An example would clarify the concept. If a medical intervention cost ₹1,00,000 in 2024, a 13% medical trend(gross)  would increase its cost to ₹1,13,000 in 2025. Healthcare costs are rising significantly faster than general Inflation.

The annual (Net) medical trend rate of 8.8% shows the increase in medical costs after adjusting for general Inflation. It is Net Annual Medical Trend = Gross Annual Medical Trend – Annual General Inflation rate;  13% − 4.2% = 8.8%. What does it show? It shows that medical costs increased by approximately 8.8 percentage points more than the annual general inflation rate in 2025.

Medical Inflation and annual medical trend rates – though different in meaning, inter alia show the annual increase in the cost of medical care due to increases in Hospitalisation and room charges, doctor consultation fees, higher medicine costs and usage, diagnostic tests and investigations, and surgery and treatment costs.

Health Expenditure Scenario- 

The National Health Accounts Estimates for India  2023-24 projected Total Health Expenditure (THE) for India at Rs 9,52,122 crore and per capita health expenditure at Rs 6,801.Thus, THE accounts for 3.29% of GDP. THE represents current and capital expenditure made by Government and Private Sources, including External/Donor funds. 

Current Health Expenditure (CHE) is 87.9% of THE, while capital expenditure is 12.1% of THE. Out-of-pocket expenditure ( OOPE) incurred by Households on health is Rs 4,06,197 crore, i.e., 42.66% of THE. This out-of-pocket expenditure by the household is 1.40% of GDP, or a staggering Rs 2,901 per capita. Private Health Insurance expenditure, despite recent growth, constitutes only Rs 97,167 crore (10.2% of THE). Expenditure under all Government-Financed Health Insurance Schemes taken together is Rs 33,385 crore. Interestingly, OOPE constitutes 48.52% of Current Health Expenditure (CHE).

Current Health Expenditure (CHE) data highlights the significant contribution of private healthcare to overall health spending. Private hospitals account for the largest share at 31.91% (₹2,67,186 crore), followed by pharmacies at 20.60% (₹1,72,459 crore) and government hospitals at 16.77% (₹1,40,431 crore). Other private providers, including clinics, contribute 3.95%, diagnostic laboratories 3.50%, and preventive care just 5.03%.

Thus, a substantial share of CHE goes to private hospitals and pharmacies, with diagnostics and other healthcare providers also contributing.

Medical Inflation is therefore influenced not merely by hospital costs, but by the combined cost pressures across the entire healthcare ecosystem—including medicines, diagnostics, consultations and preventive care.

Behavioural changes – 

Rising incomes, reflected in higher per capita health expenditure, declining out-of-pocket expenditure, and gradually improving access to health insurance, alongside greater health awareness, have collectively driven increased healthcare utilisation. Private health insurance, however, accounts for only about 10.2% of Total Health Expenditure (THE) and 11.6% of Current Health Expenditure (CHE), indicating significant headroom for growth. The sector is expected to expand, driven primarily by higher utilisation intensity, a growing geriatric population, a rising disease burden and wider access to secondary and tertiary healthcare. However, this growth also signals an increasingly curative, hospital-centric model of care, potentially at the expense of preventive healthcare and traditional systems of care—an undesirable shift that could have long-term implications for healthcare costs, accessibility, and overall population health.

Authored by:

Prof(Dr.) Abhijit K.Chattoraj – Chartered Insurer 

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.